File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/anae.15952
- WOS: WOS:000901327700001
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Article: Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review
Title | Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review |
---|---|
Authors | |
Issue Date | 23-Dec-2022 |
Publisher | Wiley |
Citation | Anaesthesia: Peri-operative medicine, critical care and pain, 2023, v. 78, n. 5, p. 620-625 How to Cite? |
Abstract | Propfol-remifentanil-based total intravenous anaesthesia has dominated recent clinical practice due to its favourable pharmacokinetic profile. Interruption in remifentanil supply has presented an opportunity to diversify or even avoid the use of opioids and consider adjuncts to propofol-based total intravenous anaesthesia. Propofol, while a potent hypnotic, is not an effective analgesic. The administration of opioids, along with other adjuncts such as α-2 adrenoceptor agonists, magnesium, lidocaine, ketamine and nitrous oxide provide surgical anaesthesia and avoids large doses of propofol being required. We provide an overview of both target-control and manual infusion regimes for the alternative opioids: alfentanil, sufentanil and fentanyl. The optimal combination of hypnotic-opioid dose, titration sequence and anticipated additional postoperative analgesia required depend on the chosen combination. In addition, we include a brief discussion on the role of non-opioid adjuncts in total intravenous anaesthesia, suggested doses and expected reduction in propofol dose. |
Persistent Identifier | http://hdl.handle.net/10722/328336 |
ISSN | 2023 Impact Factor: 7.5 2023 SCImago Journal Rankings: 2.400 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hughes, LM | - |
dc.contributor.author | Irwin, MG | - |
dc.contributor.author | Nestor, CC | - |
dc.date.accessioned | 2023-06-28T04:42:34Z | - |
dc.date.available | 2023-06-28T04:42:34Z | - |
dc.date.issued | 2022-12-23 | - |
dc.identifier.citation | Anaesthesia: Peri-operative medicine, critical care and pain, 2023, v. 78, n. 5, p. 620-625 | - |
dc.identifier.issn | 0003-2409 | - |
dc.identifier.uri | http://hdl.handle.net/10722/328336 | - |
dc.description.abstract | <p>Propfol-remifentanil-based total intravenous anaesthesia has dominated recent clinical practice due to its favourable pharmacokinetic profile. Interruption in remifentanil supply has presented an opportunity to diversify or even avoid the use of opioids and consider adjuncts to propofol-based total intravenous anaesthesia. Propofol, while a potent hypnotic, is not an effective analgesic. The administration of opioids, along with other adjuncts such as α-2 adrenoceptor agonists, magnesium, lidocaine, ketamine and nitrous oxide provide surgical anaesthesia and avoids large doses of propofol being required. We provide an overview of both target-control and manual infusion regimes for the alternative opioids: alfentanil, sufentanil and fentanyl. The optimal combination of hypnotic-opioid dose, titration sequence and anticipated additional postoperative analgesia required depend on the chosen combination. In addition, we include a brief discussion on the role of non-opioid adjuncts in total intravenous anaesthesia, suggested doses and expected reduction in propofol dose.<br></p> | - |
dc.language | eng | - |
dc.publisher | Wiley | - |
dc.relation.ispartof | Anaesthesia: Peri-operative medicine, critical care and pain | - |
dc.title | Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review | - |
dc.type | Article | - |
dc.identifier.doi | 10.1111/anae.15952 | - |
dc.identifier.hkuros | 344708 | - |
dc.identifier.volume | 78 | - |
dc.identifier.issue | 5 | - |
dc.identifier.spage | 620 | - |
dc.identifier.epage | 625 | - |
dc.identifier.eissn | 1365-2044 | - |
dc.identifier.isi | WOS:000901327700001 | - |
dc.identifier.issnl | 0003-2409 | - |